- Home
- AMBP vs IRON Comparison
AMBP vs IRON Comparison
Compare AMBP & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- IRON
- Stock Information
- Founded
- AMBP 2021
- IRON 2017
- Country
- AMBP Luxembourg
- IRON United States
- Employees
- AMBP N/A
- IRON N/A
- Industry
- AMBP Containers/Packaging
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- AMBP Industrials
- IRON Health Care
- Exchange
- AMBP Nasdaq
- IRON Nasdaq
- Market Cap
- AMBP 1.9B
- IRON 1.9B
- IPO Year
- AMBP N/A
- IRON N/A
- Fundamental
- Price
- AMBP $2.70
- IRON $42.17
- Analyst Decision
- AMBP Buy
- IRON Strong Buy
- Analyst Count
- AMBP 4
- IRON 10
- Target Price
- AMBP $3.30
- IRON $83.80
- AVG Volume (30 Days)
- AMBP 1.5M
- IRON 608.5K
- Earning Date
- AMBP 04-24-2025
- IRON 05-08-2025
- Dividend Yield
- AMBP 14.81%
- IRON N/A
- EPS Growth
- AMBP N/A
- IRON N/A
- EPS
- AMBP N/A
- IRON N/A
- Revenue
- AMBP $4,908,000,000.00
- IRON N/A
- Revenue This Year
- AMBP $4.89
- IRON N/A
- Revenue Next Year
- AMBP $2.45
- IRON N/A
- P/E Ratio
- AMBP N/A
- IRON N/A
- Revenue Growth
- AMBP 2.00
- IRON N/A
- 52 Week Low
- AMBP $2.50
- IRON $25.64
- 52 Week High
- AMBP $4.26
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- AMBP 44.19
- IRON 42.98
- Support Level
- AMBP $2.53
- IRON $39.20
- Resistance Level
- AMBP $2.78
- IRON $41.41
- Average True Range (ATR)
- AMBP 0.13
- IRON 4.37
- MACD
- AMBP -0.02
- IRON 0.09
- Stochastic Oscillator
- AMBP 30.43
- IRON 54.14
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.